Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nephrolithiasis
ADR ID BADD_A03021
ADR Hierarchy
20      Renal and urinary disorders
20.04      Urolithiases
20.04.01      Renal lithiasis
20.04.01.002      Nephrolithiasis
Description Formation of stones in the KIDNEY. [MeSH]
MedDRA Code 10029148
MeSH ID D053040; D007669
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Calculus kidney | Calculus of kidney | Calculus of kidney and ureter | Calculus renal | Calculus renal NOS | Crystallization kidney | Kidney calculus | Kidney crystallisation | Kidney stone | Kidney stones | Nephrolithiasis | Renal calculi | Renal calculus | Renal calculus NOS | Renal stone | Uric acid nephrolithiasis | Unilateral renal calculus | Kidney crystallization | Crystallisation kidney | Renal pelvic calcification | Nephrolithiasis recurrent | Gouty diathesis | Ureteropelvic junction stone | Renal microlithiasis | Bilateral nephrolithiasis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01475Mirabegron--
BADD_D01476Mirtazapine--
BADD_D01478Mitomycin0.000112%
BADD_D01498Morphine--
BADD_D01511Nabumetone--
BADD_D01533Naproxen0.000019%
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01550Nelfinavir mesylate--
BADD_D01564Nicotine0.000627%
BADD_D01566Nifedipine--
BADD_D01567Nilotinib0.001679%
BADD_D01582Nizatidine--
BADD_D01592Obeticholic acid0.003857%
BADD_D01595Octreotide acetate--
BADD_D01598Ofloxacin--
BADD_D01602Olmesartan0.000388%
BADD_D01617Ondansetron0.000032%
BADD_D01624Orlistat0.022621%
BADD_D01637Oxcarbazepine0.000170%
BADD_D01643Oxybutynin0.000056%
BADD_D01668Pantoprazole--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01684Pasireotide0.000186%
BADD_D01730Pentostatin--
BADD_D01735Pergolide--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 10 Pages